Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 18/20 | 0.50 |
| ▸ | PPARA | Q07869 | 17/20 | 0.50 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.48 |
| ▸ | PTGES | O14684 | 1/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.47 |
| ▸ | PPARD | Q03181 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6815608 | 1.00 | PPARG (0.50) | PPARGPPARAPTPN2PTPN1PTGES | |
| SCHEMBL6817219 | 0.86 | PPARG (0.53) | PPARGPPARAPTPN2PTPN1PPARD | |
| SCHEMBL6815602 | 0.84 | PPARG (0.50) | PPARGPPARAPTPN2PTPN1PPARD | |
| SCHEMBL9755734 | 0.80 | PPARG (0.54) | PPARGPPARAPPARD | |
| SCHEMBL6815603 | 0.80 | PPARG (0.50) | PPARGPPARAPPARD | |
| SCHEMBL6816032 | 0.78 | PPARG (0.57) | PPARGPPARAPPARD | |
| SCHEMBL7897429 | 0.78 | PPARG (0.61) | PPARGPPARAPTPN2PTPN1PPARD | |
| SCHEMBL6817025 | 0.77 | PPARG (0.51) | PPARGPPARAPPARD | |
| SCHEMBL5760933 | 0.74 | PPARG (0.52) | PPARGPPARAPTPN2PTPN1PPARD | |
| SCHEMBL5760928 | 0.74 | PPARG (0.52) | PPARGPPARAPTPN2PTPN1PPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004011446-A1 | INDANE, DIHYDROBENZOFURAN, AND TETRAHYDRONAPHTHALENE CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS ANTIDIABETICS | BAYER PHARMACEUTICALS CORPORATION (US) | 2004-02-05 | — | — | WO | disclosed |